Simon C. Cheung
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Glutamine fructose 6-phosphate transaminase-2 as a marker of mesothelial proliferations.
Journal: Histopathology
Published: March 17, 2026
TSC2, cathepsin K, and β-catenin as immunohistochemical markers for lymphangioleiomyomatosis.
Journal: Human pathology
Published: February 19, 2026
A new FTLD-TDP subtype with annexin A11 co-pathology.
Journal: Acta neuropathologica
Published: October 16, 2025
White matter pathology in FTLD caused by GRN mutations.
Journal: Acta neuropathologica
Published: November 05, 2024
Separation of Benign From Malignant Mesothelial Proliferations Using YAP-TAZ Immunohistochemistry.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 24, 2023
Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
Journal: Human pathology
Published: August 10, 2023
Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.
Journal: Acta neuropathologica
Published: March 13, 2023
Cellular activation patterns of CD10+ fibro-adipogenic progenitors across acquired disease states in human skeletal muscle biopsies.
Journal: Free neuropathology
Published: January 27, 2023
Correction to: Accumulation of TMEM106B C‑terminal fragments in neurodegenerative disease and aging.
Correction to: Accumulation of TMEM106B C‑terminal fragments in neurodegenerative disease and aging.
Journal: Acta neuropathologica
Published: January 06, 2023
C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.
Journal: Brain : a journal of neurology
Published: December 13, 2022
Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
Journal: Acta neuropathologica
Published: October 24, 2022
Last Updated: 09/26/2026